Menu
Sign In Pricing Add Podcast

BackTable Urology

Ep. 210 Personalizing ADT Across the Prostate Cancer Spectrum with Dr. Rana McKay

217.714 - 235.509 Dr. Rana McKay

And, you know, there's still a role for that even in the modern era, if you will, if we think about the cost of care and in people who are going to be on indefinite ADT without any reason to discontinue therapy, it still plays a role in the modern era for a select number of patients.

0
💬 0

Comments

There are no comments yet.

Log in to comment.